drugset / Trial / NCT00204334

Effects of Anemia Correction on Vascular and Monocyte Function in Renal Transplant Recipients

NCT00204334 ↗

Phase 4 Completed 60 enrolled University Hospital Muenster Amgen · collab
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Correction of anaemia in renal transplant recipients by parenteral application of recombinant erythropoietin and if necessary iron will improve large artery function (endothelial function and elasticity), as assessed by ultrasound techniques and applanation tonometry. The changes in large artery function will be reflected by changes in serological markers of endothelial function and oxidative stress and by changes in monocyte function and apoptosis. There are gender differences in the responses of vascular function to correction of anemia. Besides improvement of large artery function, correction of anemia will also affect parameters of graft function, i.e. glomerular and tubular proteinuria.

Timeline

Start
2005-06
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject darbopoeitin Protein / enzyme biologic — Other

Indications